FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979357103> ?p ?o ?g. }

• W2979357103 abstract "Abstract Abstract 3436 Background: Aplastic anemia (AA) is characterized by a reduced number of hematopoietic stem cells (HSCs). It has been proposed that immunological injury in HSCs leads to reduced numbers of stem cells in the bone marrow. In addition, expression of the critical regulator of hematopoiesis GATA-2 is decreased in CD34-positive cells in AA (Fujimaki et al. Br J Haematol 2001). Despite the compelling results described above, only limited information has emerged regarding intrinsic abnormalities of hematopoietic stem cells in AA. It has been demonstrated that HOXB4 induces HSC expansion ex vivo (Antonchuk et al. Cell 2002), and restoring HOXB4 protein in HSCs from bone marrow failure patients promotes HSC expansion (Tang et al. Br J Haematol 2009). In conjunction with the evidence that recent genome-wide analysis of GATA factor chromatin occupancy identified GATA-2 peak at HOXB4 promoter (Fujiwara et al. Mol Cell 2009), we hypothesized that GATA-2 directly regulates HOXB4 expression in HSCs, which might contribute to the pathogenesis of AA. Here, we investigated possible link between GATA-2 and HOXB4, and also tested if HOXB4 is deregulated in CD34-positive cells from patients with AA. Method: For GATA-2 overexpression, human GATA-2 coding sequence was cloned into pcDNA3.1 expression vector as well as MSCV retroviral expression vector (Clontech). For GATA-2 knockdown, siRNA specific for human GATA-2 was transfected into CD34-positive cells or K562 cells by Amaxa Nucleofector kit (Amaxa Inc.). For promoter assay, DNA fragment of the HOXB4 gene promoter region (up to −262 from 1st ATG) was cloned into pGL3-Basic (Promega), and the GATA deletion construct was subsequently created with QuickChange™Site-Directed Mutagenesis Kit (Stratagene). Quantitative chromatin immunoprecipitation (ChIP) analysis was performed using antibodies for GATA-2 (H-116, Santa Cruz). For analyzing clinical samples, informed consent was obtained in all cases and ethical considerations according to the declaration of Helsinki were followed. Results: To examine if GATA-2 and HOXB4 are functionally linked, we transfected a GATA-2 expression vector into K562 cells, and demonstrated that GATA-2 significantly upregulated endogeneous HOXB4 expression. Furthermore, siRNA-mediated GATA-2 knockdown in K562 cells significantly reduced HOXB4 expression, indicating that HOXB4 is a GATA-2 target gene. We overexpressed/reduced GATA-2 in cord blood-derived CD34+ cells, which also provided evidence for GATA-2 regulation of HOXB4 expression. Promoter analyses revealed that GATA sequence located at −160/-157 of the HOXB4 gene promoter region was required to confer luciferase activity in K562 cells. In vitro DNA binding studies and quantitative ChIP analysis revealed specific GATA-2 occupancy at a chromatin region containing this element. Finally, we demonstrated that HOXB4 gene expression was significantly decreased in CD34+ cells from patients with AA (n=10) compared to those with ITP (n=13). The expression levels of HOXB4 and GATA-2 also correlated in these populations (r=0.6573, p<0.01). Conclusion: Based on these findings, we propose that decreased expression of GATA-2 in hematopoietic stem cells of AA leads to reduced HOXB4 transcription, which may have an important role in the development and/or progression of the disease. Disclosures: No relevant conflicts of interest to declare." @default.
• W2979357103 created "2019-10-18" @default.
• W2979357103 creator A5012027495 @default.
• W2979357103 creator A5019754480 @default.
• W2979357103 creator A5032786824 @default.
• W2979357103 creator A5045362602 @default.
• W2979357103 creator A5051606627 @default.
• W2979357103 creator A5079658858 @default.
• W2979357103 creator A5081301408 @default.
• W2979357103 creator A5082206928 @default.
• W2979357103 creator A5090508237 @default.
• W2979357103 date "2011-11-18" @default.
• W2979357103 modified "2023-09-27" @default.
• W2979357103 title "Decreased Expression of HOXB4 Gene in Aplastic Anemia; Regulatory Interaction with GATA-2," @default.
• W2979357103 doi "https://doi.org/10.1182/blood.v118.21.3436.3436" @default.
• W2979357103 hasPublicationYear "2011" @default.
• W2979357103 type Work @default.
• W2979357103 sameAs 2979357103 @default.
• W2979357103 citedByCount "0" @default.
• W2979357103 crossrefType "journal-article" @default.
• W2979357103 hasAuthorship W2979357103A5012027495 @default.
• W2979357103 hasAuthorship W2979357103A5019754480 @default.
• W2979357103 hasAuthorship W2979357103A5032786824 @default.
• W2979357103 hasAuthorship W2979357103A5045362602 @default.
• W2979357103 hasAuthorship W2979357103A5051606627 @default.
• W2979357103 hasAuthorship W2979357103A5079658858 @default.
• W2979357103 hasAuthorship W2979357103A5081301408 @default.
• W2979357103 hasAuthorship W2979357103A5082206928 @default.
• W2979357103 hasAuthorship W2979357103A5090508237 @default.
• W2979357103 hasConcept C10205521 @default.
• W2979357103 hasConcept C104317684 @default.
• W2979357103 hasConcept C109159458 @default.
• W2979357103 hasConcept C153911025 @default.
• W2979357103 hasConcept C173396325 @default.
• W2979357103 hasConcept C203014093 @default.
• W2979357103 hasConcept C2780007613 @default.
• W2979357103 hasConcept C28328180 @default.
• W2979357103 hasConcept C32470452 @default.
• W2979357103 hasConcept C40767141 @default.
• W2979357103 hasConcept C502942594 @default.
• W2979357103 hasConcept C54009773 @default.
• W2979357103 hasConcept C54355233 @default.
• W2979357103 hasConcept C86803240 @default.
• W2979357103 hasConcept C95444343 @default.
• W2979357103 hasConceptScore W2979357103C10205521 @default.
• W2979357103 hasConceptScore W2979357103C104317684 @default.
• W2979357103 hasConceptScore W2979357103C109159458 @default.
• W2979357103 hasConceptScore W2979357103C153911025 @default.
• W2979357103 hasConceptScore W2979357103C173396325 @default.
• W2979357103 hasConceptScore W2979357103C203014093 @default.
• W2979357103 hasConceptScore W2979357103C2780007613 @default.
• W2979357103 hasConceptScore W2979357103C28328180 @default.
• W2979357103 hasConceptScore W2979357103C32470452 @default.
• W2979357103 hasConceptScore W2979357103C40767141 @default.
• W2979357103 hasConceptScore W2979357103C502942594 @default.
• W2979357103 hasConceptScore W2979357103C54009773 @default.
• W2979357103 hasConceptScore W2979357103C54355233 @default.
• W2979357103 hasConceptScore W2979357103C86803240 @default.
• W2979357103 hasConceptScore W2979357103C95444343 @default.
• W2979357103 hasLocation W29793571031 @default.
• W2979357103 hasOpenAccess W2979357103 @default.
• W2979357103 hasPrimaryLocation W29793571031 @default.
• W2979357103 hasRelatedWork W125451769 @default.
• W2979357103 hasRelatedWork W1823105344 @default.
• W2979357103 hasRelatedWork W197013897 @default.
• W2979357103 hasRelatedWork W2014251099 @default.
• W2979357103 hasRelatedWork W2015742390 @default.
• W2979357103 hasRelatedWork W2021751827 @default.
• W2979357103 hasRelatedWork W2023737187 @default.
• W2979357103 hasRelatedWork W2040476278 @default.
• W2979357103 hasRelatedWork W2041177276 @default.
• W2979357103 hasRelatedWork W2049117415 @default.
• W2979357103 hasRelatedWork W2167488545 @default.
• W2979357103 hasRelatedWork W2276270026 @default.
• W2979357103 hasRelatedWork W2292370633 @default.
• W2979357103 hasRelatedWork W2497153907 @default.
• W2979357103 hasRelatedWork W2577852663 @default.
• W2979357103 hasRelatedWork W2579581480 @default.
• W2979357103 hasRelatedWork W266396228 @default.
• W2979357103 hasRelatedWork W2786875851 @default.
• W2979357103 hasRelatedWork W3171712245 @default.
• W2979357103 hasRelatedWork W2435753609 @default.
• W2979357103 isParatext "false" @default.
• W2979357103 isRetracted "false" @default.
• W2979357103 magId "2979357103" @default.
• W2979357103 workType "article" @default.